Takeda Pharmaceutical Company Limited

Research Takeda Pharmaceutical Company Limited (4502) on Bullrun: market cap JPY 8.14T, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker4502
• ExchangeTSE
• CountryJapan
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyJPY
• Market capJPY 8.14T
• Dividend yield3.9%
• Financial periodQ1 2026
• RevenueJPY 1.09T
• Net income-JPY 368.47B
• Free cash flowJPY 10.14B
• Gross margin62.9%

Valuation Snapshot

latest market cap is JPY 8.14T; dividend yield is 3.9%.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.

Frequently asked questions

What is Takeda Pharmaceutical Company Limited's market cap?

Takeda Pharmaceutical Company Limited's market capitalization is JPY 8.14T.

Does Takeda Pharmaceutical Company Limited pay a dividend?

Takeda Pharmaceutical Company Limited has a dividend yield of 3.9%.

What does Takeda Pharmaceutical Company Limited do?

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.